MedTrace Logo

Low-Dose Chest CT (LDCT) COVID-19 Study

NCT05031845 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2022-05-17

No results posted yet for this study

Summary

The goal of our proposed pilot study is to collect low dose CT (LDCT) findings from chest evaluations of a representative sample of 120 symptomatic Caucasian and African American, and Hispanic adults (45 each), stratified by presence of acute respiratory distress syndrome (ARDS) and COVID-19 positivity or negative PCR screening results. These data will provide us with preliminary data on the type and extent of alveolar remodeling by race and by severity of recent infectious respiratory disease. Findings from our study would will help us to determine if a larger multi-site research application to NHLBI or a similar funding agency might be possible and provide critical preliminary data on variation in LDCT findings by COVID-19 attributable respiratory health, race, and other risk factors (e.g., smoking history, comorbidities, and socioeconomic status).

Conditions

  • Covid19

Sponsors & Collaborators

  • Garfield Memorial Fund

    collaborator OTHER

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Douglas W Roblin, PhD · Kaiser Permanente

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-08
Primary Completion
2021-12-30
Completion
2021-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05031845 on ClinicalTrials.gov